174 related articles for article (PubMed ID: 33036960)
1. Treatment Trends and Cost Associated With Peyronie's Disease.
Loftus CJ; Rajanahally S; Holt SK; Raheem OA; Ostrowski KA; Walsh TJ
Sex Med; 2020 Dec; 8(4):673-678. PubMed ID: 33036960
[TBL] [Abstract][Full Text] [Related]
2. Cost of Intralesional Collagenase Clostridium Histiolyticum Therapy Versus Surgery for the Management of Peyronie's Disease: A Claims-Based Analysis (2009-2019).
Walton EL; Quinn TP; Mulloy E; Patil D; Mehta A
Sex Med; 2022 Jun; 10(3):100517. PubMed ID: 35461065
[TBL] [Abstract][Full Text] [Related]
3. Treatment Patterns and Healthcare Outcomes with Collagenase Clostridium Histolyticum vs Surgery in Peyronie's Disease: A Retrospective Claims Database Analysis.
Trost L; Huang H; Han X; Burudpakdee C; Hu Y
Sex Med; 2021 Apr; 9(2):100321. PubMed ID: 33684795
[TBL] [Abstract][Full Text] [Related]
4. Peyronie's disease: contemporary review of non-surgical treatment.
Levine LA
Transl Androl Urol; 2013 Mar; 2(1):39-44. PubMed ID: 26816722
[TBL] [Abstract][Full Text] [Related]
5. Intralesional Collagenase Clostridium histolyticum Causes Meaningful Improvement in Men with Peyronie's Disease: Results of a Multi-Institutional Analysis.
Hellstrom WJG; Tue Nguyen HM; Alzweri L; Chung A; Virasoro R; Tapscott A; Ziegelmann M; Trost L; Gelbard M
J Urol; 2019 Apr; 201(4):777-782. PubMed ID: 30672843
[TBL] [Abstract][Full Text] [Related]
6. Intralesional injection of the calcium channel blocker Verapamil in Peyronie's disease: A critical review.
Asali M; Asali M
Arch Ital Urol Androl; 2020 Oct; 92(3):. PubMed ID: 33016057
[TBL] [Abstract][Full Text] [Related]
7. The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study.
Jordan GH
J Sex Med; 2008 Jan; 5(1):180-7. PubMed ID: 18173766
[TBL] [Abstract][Full Text] [Related]
8. Review of Intralesional Collagenase Clostridium Histolyticum Injection Therapy and Related Combination Therapies in the Treatment of Peyronie's Disease (an Update).
Natale C; McLellan DM; Yousif A; Hellstrom WJG
Sex Med Rev; 2021 Apr; 9(2):340-349. PubMed ID: 32199788
[TBL] [Abstract][Full Text] [Related]
9. Intralesional Injection Therapy and Atypical Peyronie's Disease: A Systematic Review.
Choi EJ; Xu P; El-Khatib FM; Yafi FA
Sex Med Rev; 2021 Jul; 9(3):434-444. PubMed ID: 32660728
[TBL] [Abstract][Full Text] [Related]
10. Intralesional collagenase in the treatment of Peyronie's disease.
Honig SC
Ther Adv Urol; 2014 Apr; 6(2):47-53. PubMed ID: 24688600
[TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness of Intralesional Therapy for Peyronie's Disease in Controlled Clinical Studies: A Systematic Review and Network Meta-Analysis.
Russo GI; Cacciamani G; Cocci A; Kessler TM; Morgia G; Serefoglu EC; Albersen M; Verze P;
J Sex Med; 2019 Feb; 16(2):289-299. PubMed ID: 30692028
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological Management of Peyronie's Disease.
Trost LW; Gur S; Hellstrom WJ
Drugs; 2007; 67(4):527-45. PubMed ID: 17352513
[TBL] [Abstract][Full Text] [Related]
13. Impact of the Advent of Collagenase Clostridium Histolyticum on the Surgical Management of Peyronie's Disease: A Population-Based Analysis.
Sukumar S; Pijush DB; Brandes S
J Sex Med; 2020 Jan; 17(1):111-116. PubMed ID: 31759930
[TBL] [Abstract][Full Text] [Related]
14. Peyronie's disease - outcomes of collagenase
Mefford AT; Raheem O; Yafi FA; Alzweri LM
Arab J Urol; 2021; 19(3):363-369. PubMed ID: 34552787
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and safety of local injections treatments for Peyronie's disease: Review of the literature].
Rod X; Akakpo W; Roupret M
Prog Urol; 2021 Dec; 31(16):1072-1079. PubMed ID: 34148769
[TBL] [Abstract][Full Text] [Related]
16. Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial.
Greenfield JM; Shah SJ; Levine LA
J Urol; 2007 Mar; 177(3):972-5. PubMed ID: 17296390
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Curvature Improvement in Men With Peyronie's Disease Treated With Intralesional Collagenase Clostridium Histolyticum.
Flores JM; Nascimento B; Punjani N; Salter CA; Bernie HL; Taniguchi H; Miranda E; Terrier JE; Schofield E; Jenkins L; Mulhall JP
J Sex Med; 2022 Nov; 19(11):1680-1686. PubMed ID: 36127227
[TBL] [Abstract][Full Text] [Related]
18. Changes in the Effects of Peyronie's Disease After Treatment With Collagenase Clostridium histolyticum: Male Patients and Their Female Partners.
Goldstein I; Knoll LD; Lipshultz LI; Smith T; Kaufman GJ; McMahon CG
Sex Med; 2017 Jun; 5(2):e124-e130. PubMed ID: 28395998
[TBL] [Abstract][Full Text] [Related]
19. At what cost is collagenase clostridium histolyticum viable for treating Peyronie's disease in a public healthcare system?
Harvey N; Pearce I
Andrology; 2020 Sep; 8(5):1304-1311. PubMed ID: 32459883
[TBL] [Abstract][Full Text] [Related]
20. Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study.
Rehman J; Benet A; Melman A
Urology; 1998 Apr; 51(4):620-6. PubMed ID: 9586617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
